El interés en corto de Mill City Ventures III da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Mill City Ventures III. Los datos de interés en corto se actualizan cada dos semanas.

Mill City Ventures III (NASDAQ:MCVT) Bolsa, Informe de interés en corto

Mill City Ventures III

Mill City Ventures III Ltd is a non-bank lender and specialty finance company. The company is engaged in the business of providing short-term specialty finance solutions primarily to private businesses, micro-and small-cap public companies, and high-net-worth individuals. The principal specialty finance solutions that they provide are high-interest short-term lending arrangements. Typically, these lending arrangements involve obtaining collateral as security for the borrower's repayment of funds, or personal guarantees from the principals or affiliates of the borrower.

Mill City Ventures III, Ltd. - Common Stock

Mill City Ventures III Ltd

News

Buybacks

MCVT

Mill City Ventures Announces $2M Stock Repurchase Program

Mill City Ventures III (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCVT#NASDAQ">MCVT</a>) reported quarterly earnings of $0.06 per share. This is a 500 percent increase over earnings of $0.01 per share from the same period last year. The company reported $888.63 thousand in sales this quarter. This is a 2.08 percent decrease over sales of $907.50 thousand the same period last year.

Earnings

Mill City Ventures III Q2 EPS $0.06 Up From $0.01 YoY, Sales $888.63K Down From $907.50K YoY

Mill City Ventures III On Aug. 14 Reported Q2 EPS $0.06 Up From $0.01 YoY

WIIM

ACGL

AGNC

ARES

BBAR

BBDO

CRBG

ITUB

TREE

Shares of financial stocks are trading higher amid overall market strength after the fed maintained interest rates at current levels.

Mill City Ventures III Audited Consolidated Financial Statements For Period Ended Dec 31, 2022 Should No Longer Be Relied Upon

Mill City Ventures III (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCVT#NASDAQ">MCVT</a>) reported $847.52 thousand in sales this quarter. This is a 24.96 percent increase over sales of $678.21 thousand the same period last year.
2022 Highlights
<ul>
<li>Investment income from lending operations increased&nbsp;24.9%&nbsp;to&nbsp;$847,518&nbsp;in the three-month period ended December 31, 2022, from&nbsp;$678,209&nbsp;in the prior year period. For the 2022 full year, investment income was&nbsp;$4,199,453&nbsp;compared to&nbsp;$2,656,201&nbsp;in 2021, a&nbsp;$1,543,252&nbsp;or&nbsp;58%&nbsp;increase.</li>
<li>Pre-tax earnings from lending operations were&nbsp;$316,506&nbsp;in the three-month period ended December 31, 2022, compared to&nbsp;$347,054&nbsp;in the prior year period. For the 2022 full year, net gain from lending operations increased to&nbsp;$1,440,576&nbsp;from&nbsp;$1,301,450, a&nbsp;$139,126&nbsp;or&nbsp;10.6%&nbsp;increase.
<ul>
<li>Shareholder equity increased to&nbsp;$18,342,339&nbsp;from&nbsp;$13,414,048&nbsp;at December 31, 2021.</li>
</ul>
</li>
</ul>

Mill City Ventures III Q4 Sales $847.52K Up From $678.21K YoY; Investment Income From Lending Operations Increases 58%; Shareholder Equity Increases 36.7%

<h3>Gainers</h3>
<ul>
<li>World Acceptance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRLD#NASDAQ">WRLD</a>) stock moved upwards by 22.9% to $99.57 during Thursday's regular session. Trading volume for this security as of 12:30 EST is 134.7K, which is 154.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $623.0 million. As per the press release, Q3 earnings came out today. </li>
<li>Metalpha Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MATH#NASDAQ">MATH</a>) stock rose 14.35% to $0.58. The market value of their outstanding shares is at $15.5 million. </li>
<li>LendingTree (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TREE#NASDAQ">TREE</a>) shares rose 9.89% to $35.27. Trading volume for this security as of 12:30 EST is 183.5K, which is 66.2% of its average full-day volume over the last 100 days. The company's market cap stands at $451.0 million. </li>
<li>Mill City Ventures III (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCVT#NASDAQ">MCVT</a>) shares rose 9.65% to $2.51. The company's market cap stands at $15.5 million. </li>
<li>Value Line (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VALU#NASDAQ">VALU</a>) shares rose 8.93% to $54.35. The market value of their outstanding shares is at $513.6 million. </li>
<li>Pintec Technology Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PT#NASDAQ">PT</a>) stock increased by 8.57% to $0.38. The company's market cap stands at $3.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Customers Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CUBI#NYSE">CUBI</a>) shares fell 19.1% to $25.75 during Thursday's regular session. Trading volume for Customers Bancorp's stock is 1.1 million as of 12:30 EST. This is 347.2% of its average full-day volume over the last 100 days. The company's market cap stands at $837.2 million. As per the press release, Q4 earnings came out yesterday. </li>
<li>Alvarium Tiedemann Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALTI#NASDAQ">ALTI</a>) shares declined by 12.8% to $13.43. The current volume of 179.8K shares is 95.9% of Alvarium Tiedemann Hldgs's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $737.2 million. </li>
<li>LendingClub (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LC#NYSE">LC</a>) stock declined by 12.09% to $9.09. LendingClub's stock is trading at a volume of 4.6 million shares as of 12:30 EST. This is 270.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $955.2 million. As per the press release, Q4 earnings came out yesterday. </li>
<li>Alerus Finl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALRS#NASDAQ">ALRS</a>) stock fell 9.65% to $20.33. The current volume of 65.1K shares is 212.6% of Alerus Finl's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $406.3 million. As per the press release, Q4 earnings came out yesterday. </li>
<li>ConnectOne Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNOB#NASDAQ">CNOB</a>) shares decreased by 9.64% to $22.07. The current volume of 189.1K shares is 142.7% of ConnectOne Bancorp's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $866.2 million. As per the news, the Q4 earnings report came out today. </li>
<li>Kearny Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRNY#NASDAQ">KRNY</a>) stock decreased by 9.02% to $9.4. Kearny Financial's stock is trading at a volume of 134.7K shares as of 12:30 EST. This is 52.7% of its average full-day volume over the last 100 days. The company's market cap stands at $635.0 million. The company's, Q2 earnings came out today. 
See Also: <a href="http://www.benzinga.com/money/best-financial-services-stocks/" title="www.benzinga.com/money/best-financial-services-stocks/">www.benzinga.com/money/best-financial-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

ALRS

ALTI

CNOB

CUBI

KRNY

MATH

VALU

WRLD

12 Financials Stocks Moving In Thursday's Intraday Session

COIN

EHTH

FRBK

GOCO

MSCI

NCPL

OPRT

SOFI

THCH

TROW

Shares of banks and financial services companies are trading higher on continued hopes of a peaking labor market and potentially slowed inflation following Friday economic data. Softer inflation could lead to less aggressive Fed monetary policy and positively impact lending.

Trading Ideas

Mill City Ventures III Shares Resume Trading; Shares Down ~2% Premarket

Mill City Ventures III, Ltd. Shares To Resume At 7:30 a.m. ET

Mill City Ventures III, Ltd. (&quot;Mill City&quot;) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCVT#NASDAQ">MCVT</a>), a specialty short-term finance and non-bank lender, announced today that it has entered into a non-binding letter of intent for a merger transaction with Mustang Funding, LLC dba Mustang Litigation Funding (&quot;Mustang&quot;), a Delaware limited liability company owning and operating a Minneapolis-based litigation finance business focusing on the long-term capital needs of law firms, plaintiffs and vendors. Mustang has associated offices in Plymouth Meeting, Pennsylvania and Sarasota, Florida. The letter of intent contemplates Mill City&#39;s acquisition of Mustang through a legal structure that is to be determined in connection with reaching a definitive agreement, but with the owners of Mustang receiving a sufficient number of shares of Mill City common stock such that they would own&nbsp;80%&nbsp;of the total number of issued and outstanding shares of Mill City common stock on a post-transaction basis. The letter of intent is non-binding and obligates the parties only to work cooperatively and in good faith for the purpose of negotiating and entering into a definitive agreement governing the transaction.
The letter of intent sets forth certain conditions precedent to any closing of the transaction, and a definitive agreement, if reached, would likely set forth additional customary and negotiated conditions to any such closing. The conditions identified in the letter of intent include the completion of due diligence to the satisfaction of the both parties, a financing-based condition, the consummation of a short-term loan by Mill City to Mustang, the approval of the owners of Mustang and the shareholders of Mill City, together with any related regulatory approvals that may be required, including any required approval by Nasdaq of the continued listing of Mill City common stock after any closing. Any definitive agreement that may be reached is expected to contain other customary and negotiated terms and conditions, and may contain terms and conditions different from those contemplated in the letter of intent.

Mill City Ventures III, Ltd. Enters Into Letter Of Intent To Acquire Mustang Funding, LLC

Mill City Ventures III, Ltd. Shares Halted, News Pending

&nbsp;Mill City Ventures III, Ltd.&nbsp;<a href="https://pr.report/nG02jLR3">(NASDAQ:</a><a href="https://www.benzinga.com/stock/MCVT#NASDAQ">MCVT</a>) (&quot;Mill City&quot; or the &quot;Company&quot;) a non-bank lender and specialty finance company, today announced financial results for the three-month and nine-month periods ended September 30, 2022.
3Q 2022 Highlights
<ul>
<li>Investment income from lending operations increased&nbsp;47.5%&nbsp;to&nbsp;$1,115,224&nbsp;in the three-month period ended September 30, 2022, from&nbsp;$755,601&nbsp;in the prior year period. For the nine-month period, investment income was&nbsp;$3,351,935&nbsp;compared to&nbsp;$1,977,992&nbsp;in the prior year period, a&nbsp;69%&nbsp;increase.</li>
<li>Net loss in the&nbsp;third quarter&nbsp;was ($64,568) compared to a gain of&nbsp;$516,019&nbsp;in the prior year period. The loss in the&nbsp;third quarter&nbsp;was driven primarily by professional fees incurred during the quarter related to the Company&#39;s public offering and listing on Nasdaq. In the nine-month period, net gain from lending operations increased to&nbsp;$1,124,070&nbsp;from&nbsp;$954,396&nbsp;in the prior year period, a&nbsp;17.7%&nbsp;increase.</li>
<li>Shareholder equity increased to&nbsp;$18,658,595&nbsp;from&nbsp;$13,414,049&nbsp;at December 31, 2021</li>
<li>At September 30, 2022, the Company had&nbsp;$1,861,650&nbsp;in cash, compared with&nbsp;$1,936,148&nbsp;at December 31, 2021.</li>
</ul>
Commenting on the quarter, Chief Executive Officer Douglas M. Polinsky said, &quot;Our&nbsp;third quarter&nbsp;results reflect the continued robust demand for our short-term loans as income from operations increased on a three-month and nine-month basis. Our net results include professional fees we incurred in connection with our public offering and uplisting to Nasdaq in August, and as part of our efforts to raise our visibility with the investment community and grow our business. The market demand for our lending solutions continues to be the main driver our growth, and we intend to remain opportunistic about acquisitions that may accelerate that growth.&quot;

Mill City Ventures III Reports 2022 Q3 Financial Results Investment Income From Lending Operations Increases 47.5% To $1,115,224 Shareholder Equity Increases 39%

Mill City Ventures III, Ltd. (&ldquo;Mill City&rdquo; or the &ldquo;Company&rdquo;) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCVT#NASDAQ">MCVT</a>) announced today its funding of a settled insurance claim in the amount of&nbsp;$855,000.&nbsp;&nbsp;The related short-term note is expected to mature in 120 days and involve an annualized return of&nbsp;33.5%.
Mill City Chief Executive Officer, Douglas M. Polinsky, said, &ldquo;This latest closing is one more example of our ability to profitably service a growing need in the financing markets. With rising inflation and rapidly rising interest rates, borrowers are facing an increasing number of hurdles to clear in their efforts to access capital on a short-term basis.&nbsp;&nbsp;There continues to be a large funding gap between the needs of small- and medium-sized businesses and the institution-based financing available to them.&nbsp;&nbsp;Our ability to quickly create financing solutions for a variety of needs is proving to be a significant growth engine for Mill City Ventures.&rdquo;

Legal

Mill City Funds $855,000 Short-Term Insurance Settlement

A wind of change is blowing through the financial industry as more people drift toward nonbank institutions for their borrowing needs.
In 1974, banks&nbsp;<a href="https://www.fdic.gov/analysis/quarterly-banking-profile/fdic-quarterly/2019-vol13-4/fdic-v13n4-3q2019-article1.pdf">controlled</a>&nbsp;the lending industry, holding 62% of the total loans. Almost five decades later, nonbanks&nbsp;<a href="https://www.wsj.com/articles/nonbank-lenders-are-dominating-the-mortgage-market-11624367460?mod=business_lead_pos6">issued</a>&nbsp;68% of all U.S. mortgages.&nbsp;
A report by the&nbsp;<a href="https://www.bis.org/publ/qtrpdf/r_qt2203c.htm#:~:text=Total%20new%20syndicated%20lending%20to,%2C%20left%2Dhand%20panel).">Bank for International Settlements (BIS)</a>&nbsp;indicated that syndicated lending to nonfinancial corporations increased substantially, from less than $300 billion in 1990 to around $4.75 trillion in 2019. Nonbank lending increased from $20 billion to $410 billion per year over the same period.
<h2>Specialty Financing</h2>
These nonbanks&rsquo; ability to meet the need for alternative or specialty financing may be what&rsquo;s driving their increase in lending.
Specialty finance firms make it easier for consumers and small to mid-size businesses to get loans they may find difficult to obtain from traditional banks.
They have easily won the hearts of some customers who were yearning to bypass long bureaucratic processes in favor of more straightforward procedures like completing loan applications and payments digitally with no initial fees and low-interest rates.
Thanks to this financing option, people who do not qualify for a traditional bank loan because of bad credit history are now turning to the alternative lending market for their capital needs.
In this context, companies like Oxford Square Capital Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/oxsq#NASDAQ">OXSQ</a>), Mill City Ventures III Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mcvt#NASDAQ">MCVT</a>), Manhattan Bridge Capital Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/loan#NASDAQ">LOAN</a>), and U.S. Global Investors (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grow#NASDAQ">GROW</a>) have flourished over recent years.
<h2>Meeting Demand</h2>
As borrowers continue seeking alternative financing sources, <a href="https://www.millcityventures3.com/">Mill City Ventures III Ltd</a>, a short-term nonbank lending and specialty finance company could be answering this demand with its specialty financing solutions
Founded in January 2006,&nbsp;Mill City specialized in providing bespoke short-term lending solutions to public and private companies facing short-term liquidity issues.&nbsp;
Mill City ordinarily provides nonbank lending and specialty finance to companies and individuals with both collateral and a short-term source of liquidity anticipated to be available by the time the loan matures. The principal specialty finance solutions the company provides are high-interest, short-term lending arrangements.
The loans the company provides typically have maturities of nine months or less and involve a pledge of collateral or, in the case of loans made to companies, personal guarantees by the borrower&rsquo;s principals.
Since commencing short-term nonbank lending operations in January 2020, both the average loan size and weighted interest rate have increased year over year.
<a href="https://profiles.smallcapsdaily.com/mcvt/"><img alt="screenshot_2022-11-02_at_5.52.58_pm.png" src="https://www.benzinga.com/files/u240220/screenshot_2022-11-02_at_5.52.58_pm.png" style="height:349px; width:650px" /></a>
<h2>Financials</h2>
The company&rsquo;s product offerings could be positively affecting growth, as shown in Mill City&rsquo;s recent&nbsp;<a href="https://www.benzinga.com/pressreleases/22/08/ac28513935/mill-city-ventures-iii-ltd-reports-2022-second-quarter-financial-results">financial results</a>&nbsp;for the three- and six-month periods that ended June 30, which could be good news for investors.
<h3>Q2 2022 Highlights</h3>
<ul>
<li>Investment income from lending operations increased 83% to $1.24 million in the three months ended June 30, up from $675,549 in the prior year.&nbsp;</li>
</ul>
For the six-month period, investment income from lending operations was $2.24 million, compared to $1.2 million at the same time a year ago, an 83% increase.
<ul>
<li>Pretax earnings from lending operations increased in the second quarter to $734,250 from $425,393 in the prior year, a 73% increase.&nbsp;</li>
<li>In the six-month period, pretax earnings from lending operations reached $1.2 million compared to $438,377 in the prior year period, a 171% increase.</li>
<li>Shareholder equity increased to $14.4 million on June 30, 2022, from $13.4 million on Dec. 31, 2021.</li>
<li>As of June 30, 2022, the company had $629,572 in cash, compared with $1,936,148 as of Dec. 31, 2021.</li>
</ul>
Featured photo by <a href="https://www.shutterstock.com/g/Kritchanut">Atstock Productions</a> on&nbsp; <a href="https://www.shutterstock.com/image-photo/close-businessman-hand-giving-money-russian-687049846">Shutterstock</a>
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Penny Stocks

Markets

GROW

LOAN

OXSQ

As More Consumers And Investors Seek Alternative Financing, This Company's Specialty Financing Could Provide Answers

<h3>Gainers</h3>
<ul>
<li>Abiomed, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/abmd#NASDAQ">ABMD</a>) shares surged 49.9% to settle at $377.82 on Tuesday after Johnson &amp; Johnson announced it <a href="https://www.benzinga.com/quote/ABMD/analyst-ratings"> will acquire the company </a>. Also, the company reported better-than-expected Q2 adjusted EPS results.</li>
<li>Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sonn#NASDAQ">SONN</a>) gained 46.6% to close at $2.83. Sonnet BioTherapeutics recently announced an agreement with Janssen for the evaluation of three Sonnet product candidates.</li>
<li>NLS Pharmaceutics AG (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nlsp#NASDAQ">NLSP</a>) gained 44% to settle at $0.74. NLS Pharmaceutics was granted FDA Orpha Drug Designation for Quilience (Mazindol) for the treatment of idiopathic hypersomnia.</li>
<li>Ucommune International Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/uk#NASDAQ">UK</a>) jumped 34.7% to close at $1.71.</li>
<li>Safe-T Group Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sfet#NASDAQ">SFET</a>) shares gained 30.7% to close at $0.3921 on Tuesday as the company said its privacy application reached over 5,000,000 downloads.</li>
<li>Aravive, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arav#NASDAQ">ARAV</a>) gained 30.5% to close at $1.71.</li>
<li>Sonoma Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snoa#NASDAQ">SNOA</a>) jumped 25.1% to settle at $2.49.</li>
<li>Mill City Ventures III, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mcvt#NASDAQ">MCVT</a>) gained 24.1% to close at $2.73.</li>
<li>IDEX Biometrics ASA (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/idba#NASDAQ">IDBA</a>) climbed 23% to close at $7.27.</li>
<li>Harsco Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hsc#NYSE">HSC</a>) climbed 22.5% to close at $6.48 after the company reported better-than-expected Q3 sales results and raised FY22 adjusted EPS guidance.</li>
<li>Cabaletta Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/caba#NASDAQ">CABA</a>) gained 21.9% to close at $2.06.</li>
<li>Baosheng Media Group Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/baos#NASDAQ">BAOS</a>) rose 21.2% to close at $1.05.</li>
<li>Anebulo Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aneb#NASDAQ">ANEB</a>) surged 20.3% to settle at $2.90.</li>
<li>Humanigen, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hgen#NASDAQ">HGEN</a>) gained 19.9% to settle at $0.1680.</li>
<li>NantHealth, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nh#NASDAQ">NH</a>) jumped 19.6% to close at $0.3886.</li>
<li>Tarena International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tedu#NASDAQ">TEDU</a>) gained 18.3% to settle at $5.49.</li>
<li>Leju Holdings Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/leju#NYSE">LEJU</a>) rose 18.2% to close at $1.56.</li>
<li>IronNet, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/irnt#NYSE">IRNT</a>) gained 17.4% to close at $0.8338. IronNet announced receipt of continued listing standard notice from NYSE.</li>
<li>Pharming Group N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/phar#NASDAQ">PHAR</a>) gained 17.2% to close at $11.40.</li>
<li>Ambow Education Holding Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ambo#NYSE">AMBO</a>) surged 16.8% to close at $0.3038.</li>
<li>ReTo Eco-Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/reto#NASDAQ">RETO</a>) climbed 16.4% to close at $0.6399.</li>
<li>Atai Life Sciences N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atai#NASDAQ">ATAI</a>) gained 14.6% to close at $3.38 after Loop Capital initiated coverage on the stock with a Buy rating and a $18 price target.</li>
<li>Harmony Biosciences Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hrmy#NASDAQ">HRMY</a>) rose 14% to settle at $59.26 after the company reported better-than-expected Q3 EPS and sales results.</li>
<li>Community Health Systems, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cyh#NYSE">CYH</a>) gained 13.6% to close at $3.26. Community Health Systems recently posted a Q3 loss of $0.52 per share.</li>
<li>Intercept Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/icpt#NASDAQ">ICPT</a>) jumped 13.4% to settle at $15.73 after the company reported better-than-expected Q3 sales results.</li>
<li>Carvana Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cvna#NYSE">CVNA</a>) gained 12.9% to close at $15.28 after JP Morgan upgraded the stock from Underweight to Neutral and announced a $20 price target.</li>
<li>Zai Lab Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zlab#NASDAQ">ZLAB</a>) shares jumped 12.3% to close at $25.02. Shares of Chinese companies traded higher amid unconfirmed rumors suggesting a committee was exploring ways to ease China&#39;s &#39;Zero COVID&#39; policy. A Chinese Foreign Ministry spokesman said he was unaware of a committee.</li>
<li>Kiniksa Pharmaceuticals, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/knsa#NASDAQ">KNSA</a>) climbed 12.1% to close at $12.80 after the company posted a profit for the third quarter.</li>
<li>Uber Technologies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uber#NYSE">UBER</a>) rose 12% to close at $29.75 after the company reported better-than-expected Q3 sales results and Q3 monthly active platform consumers of 124 million, up 14% year over year.</li>
<li>Kanzhun Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bz#NASDAQ">BZ</a>) jumped 11.7% to close at $12.21. Shares of Chinese companies traded higher amid unconfirmed rumors suggesting a committee was exploring ways to ease China&#39;s &#39;Zero COVID&#39; policy. A Chinese Foreign Ministry spokesman said he was unaware of a committee.</li>
<li>H World Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/htht#NASDAQ">HTHT</a>) shares climbed 10.8% to close at $30.00.</li>
<li>MINISO Group Holding Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mnso#NYSE">MNSO</a>) rose 10.4% to close at $5.63.</li>
<li>IDEXX Laboratories, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/idxx#NASDAQ">IDXX</a>) surged 9.8% to settle at $394.93 after the company reported better-than-expected Q3 EPS and sales results.</li>
<li>RLX Technology Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rlx#NYSE">RLX</a>) rose 9.6% to close at $1.37 after declining over 7% on Monday.</li>
<li>Hologic, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/holx#NASDAQ">HOLX</a>) rose 9.3% to close at $74.13 after the company reported better-than-expected Q3 EPS and sales results.</li>
<li>Trip.com Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcom#NASDAQ">TCOM</a>) shares gained 8.4% to settle at $24.54 amid unconfirmed rumors suggesting a committee was exploring ways to ease China&#39;s &#39;Zero COVID&#39; policy. A Chinese Foreign Ministry spokesman said he was unaware of a committee.</li>
<li>Lattice Semiconductor Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lscc#NASDAQ">LSCC</a>) gained 8.4% to close at $52.58 after the company reported better-than-expected Q3 EPS and sales results. The company also issued Q4 sales guidance above analyst estimates.</li>
<li>Aeglea BioTherapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agle#NASDAQ">AGLE</a>) climbed 7.8% to close at $1.11. Wells Fargo recently upgraded the stock from Equal-Weight to Overweight and raised its price target from $1.5 to $2.</li>
<li>Cyxtera Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cyxt#NASDAQ">CYXT</a>) gained 6.6% to close at $2.58.</li>
<li>Blucora, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bcor#NASDAQ">BCOR</a>) gained 6.1% to close at $23.37 after the company reported better-than-expected Q3 sales results and announced it sold TaxAct for $720 million in cash.</li>
<li>iQIYI, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iq#NASDAQ">IQ</a>) rose 5.5% to close at $2.13. Shares of Chinese companies traded higher amid unconfirmed rumors suggesting a committee was exploring ways to ease China&#39;s &#39;Zero COVID&#39; policy. A Chinese Foreign Ministry spokesman said he was unaware of a committee.</li>
<li>SoFi Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sofi#NASDAQ">SOFI</a>) gained 5.3% to close at $5.73 after the company reported better-than-expected Q3 EPS and sales results and raised FY22 revenue guidance.</li>
<li>Lyft, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lyft#NASDAQ">LYFT</a>) gained 3.5% to close at $15.15 in sympathy with Uber, which reported better-than-expected Q3 sales results and Q3 monthly active platform consumers of 124 million, up 14% year over year.</li>
</ul>
&nbsp;
<h3>
Losers</h3>
<ul>
<li>Varonis Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vrns#NASDAQ">VRNS</a>) shares fell 35.5% to close at $17.27 on Tuesday after the company reported worse-than-expected Q3 results.</li>
<li>Satixfy Communications Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/satx#NYSE">SATX</a>) dipped 29.4% to close at $11.51.</li>
<li>China Liberal Education Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cleu#NASDAQ">CLEU</a>) fell 27.4% to settle at $1.14.</li>
<li>Acorda Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acor#NASDAQ">ACOR</a>) shares fell 25.2% to close at $0.8001 after jumping over 63% on Monday.</li>
<li>Catalent, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ctlt#NYSE">CTLT</a>) fell 24.7% to close at $49.53 after the company reported worse-than-expected Q1 EPS and sales results and issued FY23 sales guidance below estimates.</li>
<li>Selina Hospitality PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/slna#NASDAQ">SLNA</a>) fell 22.9% to close at $9.94.</li>
<li>LMF Acquisition Opportunities, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/icu#NASDAQ">ICU</a>) fell 22.1% to close at $8.48.</li>
<li>Coeptis Therapeutics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coep#NASDAQ">COEP</a>) dropped 21.4% to close at $5.11. Coeptis Therapeutics announced closing of business combination with Bull Horn Holdings Corp.</li>
<li>Instil Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/til#NASDAQ">TIL</a>) fell 20.3% to settle at $2.63. Instil Bio voluntarily paused enrollment of its ongoing clinical trials. Cowen &amp; Co. downgraded Instil Bio from Outperform to Market Perform.</li>
<li>Solaris Oilfield Infrastructure, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/soi#NYSE">SOI</a>) fell 19.8% to settle at $10.92 following downbeat quarterly sales.</li>
<li>Vyant Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vynt#NASDAQ">VYNT</a>) fell 18.8% to close at $0.3799 after the company announced a one-for-five reverse stock split.</li>
<li>Starry Group Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/stry#NYSE">STRY</a>) dropped 18.6% to close at $0.18. Citigroup recently downgraded the stock from Neutral to Sell and lowered its price target from $3.75 to $0.25.</li>
<li>TETRA Technologies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tti#NYSE">TTI</a>) declined 18.2% to close at $4.04 following weak quarterly results.</li>
<li>Argo Blockchain plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arbk#NASDAQ">ARBK</a>) declined 18% to close at $0.9099. Argo Blockchain shares dipped around 44% on Monday after the company announced it believes its previously announced non-binding LOI with a strategic investor to raise $27 million via a subscription for ordinary shares will no longer be conssumated.</li>
<li>Perfect Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/perf#NYSE">PERF</a>) dropped 17.9% to settle at $9.02.</li>
<li>Cardio Diagnostics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cdio#NASDAQ">CDIO</a>) fell 17.3% to close at $2.35.</li>
<li>Clearwater Paper Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/clw#NYSE">CLW</a>) declined 16.8% to close at $37.00 following Q3 results. RBC Capital downgraded Clearwater Paper from Outperform to Sector Perform.</li>
<li>Zebra Technologies Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zbra#NASDAQ">ZBRA</a>) dropped 15.9% to close at $238.30 after the company reported worse-than-expected Q3 EPS and sales results. The company also issued Q4 EPS guidance below analyst estimates.</li>
<li>Myriad Genetics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mygn#NASDAQ">MYGN</a>) fell 15.6% to close at $17.50 following downbeat Q3 results.</li>
<li>The Goodyear Tire &amp; Rubber Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gt#NASDAQ">GT</a>) fell 14.9% to close at $10.81 after the company reported worse-than-expected Q3 earnings.</li>
<li>Transcat, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trns#NASDAQ">TRNS</a>) dropped 12.8% to close at $72.13 following Q2 results.</li>
<li>Paragon 28, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fna#NYSE">FNA</a>) fell 12.8% to close at $17.41. Paragon 28 filed for mixed shelf of up to $100 million.</li>
<li>Uxin Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/uxin#NASDAQ">UXIN</a>) dropped 12.6% to close at $3.60.</li>
<li>BioCryst Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bcrx#NASDAQ">BCRX</a>) fell 11.2% to close at $11.86 after the company reported Q3 earnings results and issued FY22 guidance.</li>
<li>OrthoPediatrics Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kids#NASDAQ">KIDS</a>) fell 10.7% to close at $37.96 after the company issued FY22 revenue guidance below estimates.</li>
<li>Nikola Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nkla#NASDAQ">NKLA</a>) declined 10.3% to settle at $3.40. Nikola recently announced a hydrogen supply collaboration with Keystate.</li>
<li>Harmonic Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hlit#NASDAQ">HLIT</a>) dropped 10.2% to close at $13.88 following Q3 results.</li>
<li>SeqLL Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sql#NASDAQ">SQL</a>) fell 10.1% to close at $0.5290.</li>
<li>Evolent Health, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/evh#NYSE">EVH</a>) declined 9.1% to close at $28.93. Truist Securities initiated coverage on Evolent Health with a Hold rating and announced a price target of $33.</li>
<li>Ecolab Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ecl#NYSE">ECL</a>) dropped 9% to close at $142.98 after the company reported worse-than-expected Q3 EPS results.</li>
<li>TopBuild Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bld#NYSE">BLD</a>) dropped 7.6% to close at $157.18 following Q3 results.</li>
<li>Kforce Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kfrc#NASDAQ">KFRC</a>) fell 7.5% to close at $58.53 after reporting Q3 results.</li>
<li>Avis Budget Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/car#NASDAQ">CAR</a>) fell 6.7% to close at $220.52 following Q3 results.</li>
<li>Sealed Air Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/see#NYSE">SEE</a>) dipped 6.7% to close at $44.42 after the company announced it will acquire Liquibox for $1.15 billion. The company also reported worse-than-expected Q3 sales.</li>
<li>Canopy Growth Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cgc#NASDAQ">CGC</a>) dropped 6.4% to close at $3.49.</li>
<li>Babcock &amp; Wilcox Enterprises, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bw#NYSE">BW</a>) fell 4.8% to close at $4.34.</li>
<li>Stryker Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/syk#NYSE">SYK</a>) fell 4% to close at $220.09 after the company reported worse-than-expected Q3 results and issued 2022 guidance below estimates.</li>
</ul>

Small Cap

Pre-Market Outlook

ABMD

ACOR

AGLE

AMBO

ANEB

ARAV

ARBK

ATAI

BAOS

BCOR

BCRX

CABA

Cardio Diagnostics Holdings Inc. - Common stock

CDIO

CLEU

COEP

CTLT

CVNA

CYXT

HGEN

HLIT

HOLX

HRMY

HTHT

ICPT

IDBA

IDXX

IRNT

KFRC

KIDS

KNSA

LEJU

LSCC

LYFT

MNSO

MYGN

NKLA

NLSP

PERF

PHAR

RETO

SatixFy Communications Ltd. Ordinary Share

SATX

SFET

SLNA

SNOA

SONN

STRY

TCOM

TEDU

TRNS

UBER

UXIN

VRNS

VYNT

ZBRA

ZLAB

Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday

<a href="https://profiles.smallcapsdaily.com/mcvt/">Learn more about Mill City Ventures III, Ltd. by gaining access to the latest research report.&nbsp;</a>
Going public on bigger markets gives private companies a perfect opportunity to generate capital to help further growth, reduce debt, fund research and development (R&amp;D) and take care of other business operations.
Apart from the financial upside, the company can also benefit from increased public awareness because an uplist tends to generate publicity that attracts new customers, subsequently increasing market share.
On Aug. 10, Mill City Ventures III Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mcvt#NASDAQ">MCVT</a>), a nonbank lender and specialty finance company, joined Manhattan Bridge Capital Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/loan#NASDAQ">LOAN</a>), Oxford Square Capital Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/oxsq#NASDAQ">OXSQ</a>), and U.S. Global Investors Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grow#NASDAQ">GROW</a>), which have moved to the Nasdaq (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ndaq#NASDAQ">NDAQ</a>) stock market.
Founded in January 2006, <a href="https://www.millcityventures3.com/">Mill City</a> is a nonbank specialty finance firm specializing in investments in debt and equity securities of public and private companies to fund operations facing short-term liquidity issues.
<h2>Before Commencing Trading On Nasdaq</h2>
Before it began trading on the Nasdaq Capital Market (Nasdaq), the company&nbsp;<a href="https://www.benzinga.com/news/22/08/28424175/mill-city-ventures-iii-ltd-announces-pricing-of-5-million-public-offering-to-trade-on-nasdaq-capital">revealed</a>&nbsp;the pricing of its underwritten public offering &mdash; 1.25 million shares of common stock at a public offering price of $4 per share for aggregate gross proceeds of $5 million before underwriting discounts and commissions, and other company offering expenses.
In addition, the company granted the underwriters a 45-day option to purchase up to 187,500 additional shares of common stock at the offering price, less the underwriting discount.
<h2>SEC Filling</h2>
In its filing with the U.S. Securities and Exchange Commission (SEC), Mill City identified several criteria it believes are important guidelines to meet its financial objectives. They include:
<h3>Existing Liquidity Source</h3>
The company noted that because most of its transactions involve short-term maturities, it typically seeks to identify a liquidity source for the borrower to repay them.
Examples of sources of potential liquidity may include accounts receivable, another valuable asset, or a pending payment such as a tax refund, a litigation judgment, or a settlement payment that is reasonably expected to pay out prior to the maturity of the credit provided.
<h3>Collateral Value</h3>
Mill City said it will generally seek to collateralize the obligations owed to the company.&nbsp;
&ldquo;Our ability to identify valuable collateral is a significant factor in our credit analysis and determination of the attractiveness of a potential transaction,&rdquo; the company said.
&ldquo;This analysis will often involve legal counsel, both to assist in the identification of potential collateral assets and to better understand the ease with which a security interest in the collateral may be granted, perfected and, if necessary, foreclosed upon and the relevant jurisdiction(s) involved.&rdquo;
<h3>Experienced And Capable Management</h3>
Mill City indicated that it would seek businesses with an experienced, knowledgeable and capable management teams in transactions involving business borrowers.
<h3>Competitive Position</h3>
In transactions involving business borrowers, the company said it would seek to invest in transactions with businesses that have developed, or appear poised to develop, a strong competitive position within their respective industry sector or niche.
<h3>Cash Flow</h3>
Finally, in transactions involving business borrowers, Mill City said it would seek to invest in profitable or nearly profitable businesses on an operating cash-flow basis. It will do this principally so that the business&rsquo;s operating cash flow may serve as another source of liquidity from which it may ultimately be repaid.
Read more about the SEC filing <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001425355/000141057822001009/mcvt-20220419xs1.htm">here</a>.
<h2>Strong Financials</h2>
Shortly after going public, Mill City&nbsp;<a href="https://www.benzinga.com/pressreleases/22/08/ac28513935/mill-city-ventures-iii-ltd-reports-2022-second-quarter-financial-results">announced</a>&nbsp;financial results for the three- and six-month periods that ended June 30.
<h3>Q2 2022 Highlights</h3>
<ul>
<li>Investment income from lending operations increased 83% to $1.24 million in the three-month period ended June 30, up from $675,549 in the prior year.&nbsp;</li>
</ul>
For the six-month period, investment income from lending operations was $2.24 million compared to $1.2 million in the prior year period &mdash; an 83% increase.
<ul>
<li>Pretax earnings from lending operations increased in the second quarter to $734,250 from $425,393 in the prior year, a 73% increase.&nbsp;</li>
</ul>
In the six-month period, pretax earnings from lending operations reached $1.2 million compared to $438,377 in the prior year period, a 171% increase.
<ul>
<li>Shareholder equity increased to $14.43 million from $13.41 million on Dec. 31, 2021.</li>
<li>As of June 30, the company had $629,572 in cash, compared with $1,936,148 on Dec. 31, 2021.</li>
</ul>
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Featured photo by iQoncept on <a href="https://www.shutterstock.com/image-illustration/going-public-stock-market-initial-offering-1346645558">Shutterstock</a>

Movers & Shakers

General

NDAQ

This Company's Uplisting Could Be A Catalyst For Further Growth As It Reports Q2 Financial Results

<h3>Gainers</h3>
<ul>
<li>Senti Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snti#NASDAQ">SNTI</a>) shares climbed 50.7% to close at $2.11 on Thursday after B of A Securities initiated coverage on the stock with a Buy rating and $7 price target.</li>
<li>BigBear.ai Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bbai#NYSE">BBAI</a>) climbed 30.3% to close at $1.55 after the company announced it was awarded a $14.8 million U.S. Army Global Force Information Management system contract.</li>
<li>Vertical Aerospace Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/evtl#NASDAQ">EVTL</a>) gained 27.2% to close at $9.64.</li>
<li>Avalon GloboCare Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avco#NASDAQ">AVCO</a>) gained 25.8% to close at $0.7049. Avalon GloboCare received allowance for joint U.S. Patent.</li>
<li>TuanChe Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tc#NASDAQ">TC</a>) gained 25.3% to close at $3.07. TuanChe posted a H1 loss of $0.11 per share.</li>
<li>Ocular Therapeutix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocul#NASDAQ">OCUL</a>) surged 24.2% to close at $5.13 following the company&#39;s presentation at the AAO 2022 Annual Meeting.</li>
<li>Mill City Ventures III, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mcvt#NASDAQ">MCVT</a>) climbed 23.6% to close at $2.62.</li>
<li>HeartBeam, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/beat#NASDAQ">BEAT</a>) surged 21.5% to settle at $4.18 on continued strength after the company on Wednesday announced a patent grant.</li>
<li>Sientra, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sien#NASDAQ">SIEN</a>) gained 21% to close at $0.6096. Sientra recently received regulatory approval to market breast implants in Saudi Arabia.</li>
<li>Jupiter Wellness, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jupw#NASDAQ">JUPW</a>) climbed 20.5% to close at $0.7334. Jupiter Wellness announced application for dual listing on upstream.</li>
<li>Akouos, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/akus#NASDAQ">AKUS</a>) climbed 16.8% to close at $6.30. William Blair initiated coverage on Akouos with an Outperform rating and announced a price target of $12.</li>
<li>Harrow Health, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hrow#NASDAQ">HROW</a>) rose 16.3% to close at $11.52. The FDA approved Harrow Health and Sintetica S.A&#39;s Iheezo (chloroprocaine hydrochloride ophthalmic gel) 3% for ocular surface anesthesia.</li>
<li>Stryve Foods, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snax#NASDAQ">SNAX</a>) gained 14.6% to close at $0.52.</li>
<li>Cognition Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cgtx#NASDAQ">CGTX</a>) gained 13.8% to close at $1.98 after Cantor Fitzgerald initiated coverage on the stock with an Overweight rating and $12 price target.</li>
<li>Golden Sun Education Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gsun#NASDAQ">GSUN</a>) rose 13.7% to close at $32.40.</li>
<li>Tyra Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tyra#NASDAQ">TYRA</a>) surged 13.3% to close at $8.78.</li>
<li>Immunovant, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imvt#NASDAQ">IMVT</a>) gained 12.3% to close at $5.38. Chardan Capital maintained Immunovant with a Buy and lowered the price target from $14 to $12.</li>
<li>SilverSun Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ssnt#NASDAQ">SSNT</a>) rose 11.3% to close at $2.76 after the company announced it entered into a definitive agreement and plan of merger with Rhodium Enterprises.</li>
<li>Aditxt, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adtx#NASDAQ">ADTX</a>) shares climbed 10.5% to close at $3.38. Aditxt said it has regained compliance with Nasdaq listing requirements.</li>
<li>Motus GI Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mots#NASDAQ">MOTS</a>) shares rose 9% to close at $2.55 after the company was recognized as a sole source provider by the Veterans Health Administration.</li>
<li>Performance Shipping Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pshg#NASDAQ">PSHG</a>) climbed 8.8% to close at $0.2394.</li>
<li>BK Technologies Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bkti#NYSE">BKTI</a>) rose 8.8% to close at $2.34. BK Technologies received a $1 million purchase order for BKR 5000 from Virginia Department of Forestry.</li>
<li>Ero Copper Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ero#NYSE">ERO</a>) gained 7.3% to close at $11.18.</li>
<li>Hempacco Co., Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hpco#NASDAQ">HPCO</a>) rose 7.1% to close at $2.58. Hempacco recently announced the release of Hemp Hop Smokables on <a href="http://www.HempHop.shop" title="www.HempHop.shop">www.HempHop.shop</a>.</li>
<li>Marker Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrkr#NASDAQ">MRKR</a>) gained 7% to close at $0.3734.</li>
<li>Enerpac Tool Group Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/epac#NYSE">EPAC</a>) gained 7% to close at $17.97 following upbeat Q4 results.</li>
<li>Mind Medicine (MindMed) Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnmd#NASDAQ">MNMD</a>) gained 6.2% to close at $3.44. Mind Medicine recently priced a 7.05 million share offering of common shares and warrants at $4.25 per share plus warrants.</li>
<li>Windtree Therapeutics, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wint#NASDAQ">WINT</a>) rose 6.2% to close at $0.34 after the company said Istaroxime Phase 2 study in early cardiogenic shock was published in the European Journal of Heart Failure.</li>
<li>BioRestorative Therapies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/brtx#NASDAQ">BRTX</a>) gained 5.3% to close at $2.98. Maxim Group initiated coverage on the stock with a Buy rating and $6 price target.</li>
</ul>
<h3>
Losers</h3>
<ul>
<li>Sunlight Financial Holdings Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sunl#NYSE">SUNL</a>) shares dipped 57.1% to close at $1.08 on Thursday after the company announced it is withdrawing its previously-provided full-year 2022 outlook metrics. Citigroup downgraded Sunlight Finl from Buy to Sell and lowered the price target from $4 to $2.</li>
<li>Atlis Motor Vehicles Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amv#NASDAQ">AMV</a>) shares dipped 54.8% to close at $33.95. The company recently posted a loss of $2.06 per share for the quarter ending June 30, 2022.</li>
<li>Lion Group Holding Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lghl#NASDAQ">LGHL</a>) fell 49.3% to close at $1.01.</li>
<li>MoneyLion Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ml#NYSE">ML</a>) dropped 29.5% to settle at $0.8038.</li>
<li>Twin Vee Powercats Co. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/veee#NASDAQ">VEEE</a>) fell 29% to close at $2.52 after the company priced a 2.5 million share public offering at $2.75 per share.</li>
<li>Rite Aid Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rad#NYSE">RAD</a>) dipped 28% to settle at $5.06 after the company reported worse-than-expected Q2 EPS and lowered its FY23 adjusted EBITDA guidance. The company also said it expects continued pressure on consumer spending and supply chain challenges.</li>
<li>Isoray, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/isr#NYSE">ISR</a>) fell 27.4% to close at $0.2199 after the company announced it entered into a definitive agreement to acquire Viewpoint Molecular Targeting.</li>
<li>PhaseBio Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/phas#NASDAQ">PHAS</a>) fell 26.1% to close at $0.19 after the company on Wednesday announced it received a notice that its partner SFJ Pharmaceuticals Group elected to transfer bentracimab rights to SFJ as PhaseBio failed to remedy its Going Concern Condition.</li>
<li>SAI.TECH Global Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sai#NASDAQ">SAI</a>) fell 26.1% to close at $2.26.</li>
<li>Pioneer Power Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ppsi#NASDAQ">PPSI</a>) dropped 25.5% to close at $3.09.</li>
<li>FaZe Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/faze#NASDAQ">FAZE</a>) dropped 24.9% to close at $9.26.</li>
<li>Altus Power, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amps#NYSE">AMPS</a>) fell 23.7% to close at $10.86. Altus Power priced its 7 million share secondary underwritten public offering of class A common stock at $11.50 per share.</li>
<li>PepGen Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pepg#NASDAQ">PEPG</a>) shares fell 23.5% to close at $8.36 after jumping 110% on Wednesday. PepGen reported data from PGN-EDO51&#39;s SAD study in adult healthy volunteers that suggest best-in-class exon skipping capabilities.</li>
<li>CarMax, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kmx#NYSE">KMX</a>) fell 23.5% to $66.05 after the company reported worse-than-expected Q2 results.</li>
<li>Galecto, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/glto#NASDAQ">GLTO</a>) dropped 22.1% to close at $1.87. Galecto announced results from a planned intermediate assessment of its ongoing MYLOX-1 Phase 2a trial of GB2064 for myelofibrosis.</li>
<li>SOBR Safe, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sobr#NASDAQ">SOBR</a>) fell 21.9% to close at $1.93 after the company announced pricing of a $6 million private placement priced at-the-market.</li>
<li>Pintec Technology Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pt#NASDAQ">PT</a>) fell 21.3% to close at $0.3172.</li>
<li>BiondVax Pharmaceuticals Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bvxv#NASDAQ">BVXV</a>) dropped 20.5% to close at $0.6599 after the company filed for an ADS offering.</li>
<li>Carvana Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cvna#NYSE">CVNA</a>) fell 19.7% to close at $21.57 in sympathy with CarMax after the stock plunged following the company&#39;s weak second-quarter results.</li>
<li>REE Automotive Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ree#NASDAQ">REE</a>) dropped 18.7% to close at $0.6179.</li>
<li>Kaleyra, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/klr#NYSE">KLR</a>) fell 18.6% to close at $1.05.</li>
<li>Pineapple Energy Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pegy#NASDAQ">PEGY</a>) fell 18.6% to close at $0.9036 after dipping around 23% on Wednesday. Pineapple Energy recently named Eric Ingvaldson as new Chief Financial Officer.</li>
<li>Missfresh Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mf#NASDAQ">MF</a>) fell 18.1% to close at $0.0950 after surging around 35% on Wednesday.</li>
<li>Nano Labs Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/na#NASDAQ">NA</a>) fell 17.6% to close at $1.73.</li>
<li>Milestone Scientific Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mlss#NASDAQ">MLSS</a>) dropped 17.6% to close at $0.71.</li>
<li>Qutoutiao Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qtt#NASDAQ">QTT</a>) dropped 17.1% to close at $0.5659.</li>
<li>Nordic American Tankers Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nat#NYSE">NAT</a>) fell 16.6% to close at $2.67.</li>
<li>NantHealth, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nh#NASDAQ">NH</a>) fell 16.1% to close at $0.2423.</li>
<li>Arqit Quantum Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arqq#NASDAQ">ARQQ</a>) declined 16.1% to settle at $5.75.</li>
<li>NexImmune, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nexi#NASDAQ">NEXI</a>) dropped 15.7% to close at $0.5580. NexImmune and Selexis recently signed a service agreement to develop cell lines targeting rare cancers and autoimmune diseases.</li>
<li>View, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/view#NASDAQ">VIEW</a>) fell 15% to settle at $1.30.</li>
<li>Hippo Holdings Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hipo#NYSE">HIPO</a>) dropped 14.8% to close at $0.7404.</li>
<li>MillerKnoll, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mlkn#NASDAQ">MLKN</a>) fell 14.7% to close at $16.96 after the company issued Q2 guidance below estimates. Craig-Hallum downgraded the stock from Buy to Hold and lowered its price target from $50 to $20.</li>
<li>ContextLogic Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wish#NASDAQ">WISH</a>) fell 14.5% to close at $0.8121.</li>
<li>Peloton Interactive, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pton#NASDAQ">PTON</a>) fell 14.4% to close at $5.26 as economic concerns pressurized discretionary stocks.</li>
<li>AMC Entertainment Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ape#NYSE">APE</a>) dropped 14% to close at $2.90.</li>
<li>Lufax Holding Ltd (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lu#NYSE">LU</a>) fell 12.8% to close at $2.52.</li>
<li>Worthington Industries, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wor#NYSE">WOR</a>) dipped 12.4% to close at $42.99 after the company reported Q1 earnings results.</li>
<li>ACV Auctions Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acva#NASDAQ">ACVA</a>) dipped 12% to close at $7.82.</li>
<li>Sonic Automotive, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sah#NYSE">SAH</a>) fell 11.7% to close at $42.71.</li>
<li>Orchid Island Capital, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/orc#NYSE">ORC</a>) dropped 11.5% to close at $8.22.</li>
<li>Sunrun Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/run#NASDAQ">RUN</a>) dropped 11.4% to close at $27.52. Shares of several companies in the broader industrials sector traded lower as stocks pull back after gaining on Wednesday.</li>
<li>AutoNation, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/an#NYSE">AN</a>) declined 10.4% to close at $100.77. AutoNation 10% owner Edward S. Lampert sold a total of 290,735 shares at an average price of $108.39.</li>
<li>Chimera Investment Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cim#NYSE">CIM</a>) fell 10.2% to close at $5.26.</li>
<li>5E Advanced Materials Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/feam#NASDAQ">FEAM</a>) fell 10.1% to close at $14.03 after the company reported FY22 EPS results were lower year over year.</li>
<li>NIO Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nio#NYSE">NIO</a>) dropped 10.1% to close at $15.58. Shares of Chinese companies traded lower as global equities fall amid US economic concerns and currency uncertainty.</li>
<li>Terran Orbital Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/llap#NASDAQ">LLAP</a>) fell 9.3% to close at $2.15.</li>
<li>XPeng Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/xpev#NYSE">XPEV</a>) fell 9.2% to close at $12.11. Shares of Chinese companies traded lower as global equities fell amid US economic concerns and currency uncertainty.</li>
<li>Powerbridge Technologies Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pbts#NASDAQ">PBTS</a>) fell 7.7% to close at $0.5956 after gaining around 8% on Wednesday.</li>
<li>Toast, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tost#NYSE">TOST</a>) fell 7.3% to close at $17.47 after gaining 5% on Wednesday.</li>
</ul>
&nbsp;

ACVA

ADTX

AKUS

AMPS

Alternative Asset Management Acquisition Corp

ARQQ

AVCO

BBAI

BEAT

BKTI

BRTX

BVXV

CGTX

EPAC

EVTL

FAZE

FEAM

GLTO

GSUN

HIPO

HPCO

HROW

IMVT

JUPW

LGHL

LLAP

MLKN

MLSS

MNMD

MOTS

MRKR

NEXI

OCUL

PBTS

PEGY

PEPG

PHAS

PPSI

PSHG

PTON

SIEN

SNAX

SNTI

SOBR

SSNT

Sunlight Financial Holdings, Inc. Class A Common Stock

SUNL

TOST

TYRA

VEEE

VIEW

WINT

WISH

XPEV

Why Senti Biosciences Shares Jumped Over 50%; Here Are 79 Biggest Movers From Yesterday

Cultivating a culture of saving or investing can help guarantee a comfortable financial future.
As simple as it may sound, however, stashing away money or an asset for future profit can be a daunting habit to attain because it usually requires some sacrifice.
As the global economy continues to suffer due to a series of predicaments such as the COVID-19 pandemic, the Russia-Ukraine war and high inflation, investing could help cushion shocks as the economic crisis continues.
<h2>Types Of Investments</h2>
For anyone keen on investing, it might be prudent first to consult a&nbsp;<a href="https://www.millcityventures3.com/">financial advisor</a>&nbsp;to guide and help you figure out which investment type can help meet your financial goals.
The advisor may introduce you to popular investment options such as stocks, bonds, mutual funds, index funds, exchange-traded funds (ETFs) and options.
You can also borrow to invest over the long term &mdash; through margin loans for shares or investment property loans. A margin loan lets you borrow money to invest in shares, ETFs and managed funds.
When it comes to where you could go for such loans, a few names come up &mdash; like Manhattan Bridge Capital Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/loan#NASDAQ">LOAN</a>), Oxford Square Capital Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/oxsq#NASDAQ">OXSQ</a>), U.S. Global Investors Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grow#NASDAQ">GROW</a>) and Mill City Ventures III Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mcvt#NASDAQ">MCVT</a>).
<h2>A Different Kind Of Lender?</h2>
Unlike some other players in the industry, Mill City specializes in investments in debt and equity securities of public and private companies looking to fund operations, whether for starting up, acquiring another company or fuelling growth.
Founded in January 2006, the company reports that it primarily focuses on investing in, lending to and making managerial assistance available to privately held and publicly traded companies.
Over the years, Mill City notes that it has provided non-bank lending and specialty finance to companies and individuals on both a secured and unsecured basis. The primary specialty finance solutions the company offers are high-interest, short-term lending arrangements.
Designed for individuals, business owners, real estate owners, house redevelopers and small business owners, the company&rsquo;s lending arrangements occasionally involve the company obtaining collateral as security for the borrower&rsquo;s repayment of funds.
The loans the company provides typically have maturities ranging from nine to 12 months and may involve a pledge of collateral or, in the case of loans made to companies, personal guarantees by the borrower&rsquo;s principals.
<h2>Nature Of Lending Operations</h2>
<ul>
<li>Non-bank lending and specialty finance</li>
<li>Asset-backed loans</li>
<li>Settled claim purchases</li>
<li>Tax anticipation loans</li>
<li>Real estate bridge loans</li>
<li>Litigation finance</li>
<li>Public market companies</li>
<li>Title loans</li>
<li>Opportunistic acquisitions</li>
<li>Mortgages</li>
</ul>
Since commencing non-bank lending operations in January 2020, its average loan size and weighted rate trajectory have increased year over year. This change resulted from the company&rsquo;s focus on making higher-dollar loans that usually have additional features such as the quality of the borrower and collateral levels.
<h2>Key Investment Considerations</h2>
<ul>
<li>Management has experience in entrepreneurial ventures and finance.</li>
<li>The company is not subject to many of the regulatory limitations that govern other traditional lenders or institutional competitors.</li>
<li>Mill City runs on lean operating costs, which allows for greater income statement leverage.</li>
<li>Management continually focuses on moving the blended portfolio returns up and to the right in the context of proper risk mitigation.</li>
<li>The company takes advantage of inorganic growth opportunities in the market through complementary and accretive acquisitions.</li>
</ul>
For a bespoke lender that provides custom and tailored lending to meet a customer&rsquo;s needs, Mill City could have an advantage over competitors, with a significant driver being that it is not subject to many of the regulatory limitations that govern traditional lenders or institutional competitors.
Read more about Mill City Ventures at <a href="https://www.millcityventures3.com/">millcityventures3.com</a>.
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Featured Photo by <a href="https://www.shutterstock.com/g/Tinnakorn++jorruang">Tinnakorn jorruang</a> on <a href="https://www.shutterstock.com/image-photo/cbd-hemp-oil-hand-holding-bottle-1478305652">Shutterstock</a>

Fintech news covering the emerging Financial Technology services sector

Fintech

Is This Company Outpacing The Competition As The Best Place For Loans And Investments?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Mill City Ventures III (NASDAQ:<a href="https://investorplace.com/stock-quotes/mcvt-stock-quote/">MCVT</a>) just reported results for the fourth quarter of 2023.<ul><li>Mill City Ventures III reported earnings per share of -14 cents.</li><li>The company reported revenue of $801,947.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/04/mcvt-stock-earnings-mill-city-ventures-iii-for-q4-of-2023/">MCVT Stock Earnings: Mill City Ventures III Reported Results for Q4 2023</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

MCVT Stock Earnings: Mill City Ventures III Reported Results for Q4 2023

Mill City Ventures III GAAP EPS of $0.06

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Mill City Ventures III (NASDAQ:<a href="https://investorplace.com/stock-quotes/mcvt-stock-quote/">MCVT</a>) just reported results for the first quarter of 2024.<ul><li>Mill City Ventures III reported earnings per share of 6 cents.</li><li>The company reported revenue of $832,667.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/05/mcvt-stock-earnings-mill-city-ventures-iii-for-q1-of-2024/">MCVT Stock Earnings: Mill City Ventures III Reported Results for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

MCVT Stock Earnings: Mill City Ventures III Reported Results for Q1 2024

Mill City Ventures III reports Q2 results

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Mill City Ventures III (NASDAQ:<a href="https://investorplace.com/stock-quotes/mcvt-stock-quote/">MCVT</a>) just reported results for the second quarter of 2024.<ul><li>Mill City Ventures III reported earnings per share of 6 cents.</li><li>The company reported revenue of $888,629.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/mcvt-stock-earnings-mill-city-ventures-iii-for-q2-of-2024/">MCVT Stock Earnings: Mill City Ventures III Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

MCVT Stock Earnings: Mill City Ventures III Reported Results for Q2 2024

Comments

Mill City Ventures III

Interés en corto

Mill City Ventures III (NASDAQ:MCVT) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL